Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,576 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In response to: The validity of 18F-GE180 as a TSPO imaging agent.
Albert NL, Unterrainer M, Brendel M, Kaiser L, Zweckstetter M, Cumming P, Bartenstein P. Albert NL, et al. Among authors: kaiser l. Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1208-1211. doi: 10.1007/s00259-019-04294-8. Epub 2019 Mar 2. Eur J Nucl Med Mol Imaging. 2019. PMID: 30826897 Free article. No abstract available.
3D Monte Carlo bone marrow dosimetry for Lu-177-PSMA therapy with guidance of non-invasive 3D localization of active bone marrow via Tc-99m-anti-granulocyte antibody SPECT/CT.
Gosewisch A, Ilhan H, Tattenberg S, Mairani A, Parodi K, Brosch J, Kaiser L, Gildehaus FJ, Todica A, Ziegler S, Bartenstein P, Böning G. Gosewisch A, et al. Among authors: kaiser l. EJNMMI Res. 2019 Aug 14;9(1):76. doi: 10.1186/s13550-019-0548-z. EJNMMI Res. 2019. PMID: 31414241 Free PMC article.
In response to: Anatomy of 18F-GE180, a failed radioligand for the TSPO protein.
Albert NL, Unterrainer M, Kaiser L, Brendel M, Vettermann FJ, Holzgreve A, Bartenstein P. Albert NL, et al. Among authors: kaiser l. Eur J Nucl Med Mol Imaging. 2020 Sep;47(10):2237-2241. doi: 10.1007/s00259-020-04885-w. Epub 2020 Jun 10. Eur J Nucl Med Mol Imaging. 2020. PMID: 32524162 Free PMC article. No abstract available.
Image-based dosimetry for 225Ac-PSMA-I&T therapy using quantitative SPECT.
Gosewisch A, Schleske M, Gildehaus FJ, Berg I, Kaiser L, Brosch J, Bartenstein P, Todica A, Ilhan H, Böning G. Gosewisch A, et al. Among authors: kaiser l. Eur J Nucl Med Mol Imaging. 2021 Apr;48(4):1260-1261. doi: 10.1007/s00259-020-05024-1. Epub 2020 Sep 21. Eur J Nucl Med Mol Imaging. 2021. PMID: 32959113 Free PMC article. No abstract available.
Correction to: Influence of dosimetry method on bone lesion absorbed dose estimates in PSMA therapy: application to mCRPC patients receiving Lu-177-PSMA-I&T.
Brosch-Lenz J, Uribe C, Gosewisch A, Kaiser L, Todica A, Ilhan H, Gildehaus FJ, Bartenstein P, Rahmim A, Celler A, Ziegler S, Böning G. Brosch-Lenz J, et al. Among authors: kaiser l. EJNMMI Phys. 2021 Apr 13;8(1):36. doi: 10.1186/s40658-021-00382-7. EJNMMI Phys. 2021. PMID: 33847807 Free PMC article. No abstract available.
Prediction of TERTp-mutation status in IDH-wildtype high-grade gliomas using pre-treatment dynamic [18F]FET PET radiomics.
Li Z, Kaiser L, Holzgreve A, Ruf VC, Suchorska B, Wenter V, Quach S, Herms J, Bartenstein P, Tonn JC, Unterrainer M, Albert NL. Li Z, et al. Among authors: kaiser l. Eur J Nucl Med Mol Imaging. 2021 Dec;48(13):4415-4425. doi: 10.1007/s00259-021-05526-6. Epub 2021 Sep 7. Eur J Nucl Med Mol Imaging. 2021. PMID: 34490493 Free PMC article. Clinical Trial.
1,576 results